Becton, Dickinson and Company (NYSE:BDX)
Becton, Dickinson and Company (NYSE:BDX) represented a move of -0.08 percent or $1.38 per share and closed its previous day trading session at $252.56. 1.4 Million Shares were traded in the last trading session with an Average Volume of 1.13 Million Shares. The stock currently has a Market Capitalization of 67.84 Billion.
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
The stock traded between $209.91 and $265.87 over 1-Year time period showing its price to sales ratio of 4.24. Becton, Dickinson and Company (NYSE:BDX) is currently showing an INCREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $3.45 and 200-Day Simple Moving Average of $6.3. Its Price to Free Cash Flow is 65.04 and Price to Book of 3.23.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Becton, Dickinson and Company (NYSE:BDX) reported its Actual EPS of $2.93/share. The analysts offering Earnings Estimates for the company were believing that Becton, Dickinson and Company could bring EPS of $2.93/share. The difference between Actual EPS and Estimated EPS was 0 Percent. Thus showing an Earnings Surprise of 0 Percent.
Zions Bancorporation (NASDAQ:ZION)
In the last trading session, Zions Bancorporation (NASDAQ:ZION) added its value by -0.55% closing at the price of $48.39. The stock currently has market capitalization of 9.21 Billion, with average volume of 2.48 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Zions Bancorporation (NASDAQ:ZION) is showing beta of 1.36. This particular value of beta suggests that Zions Bancorporation (NASDAQ:ZION) has historically moved 136% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Zions Bancorporation (NASDAQ:ZION) is at $3.8.
The stock currently has RSI of 48.23. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Zions Bancorporation is one of the nation’s premier financial services companies. Zions operates under local management teams and distinct brands in many western states: Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington and Wyoming. The company is a national leader in Small Business Administration lending and public finance advisory services, and is a consistent top recipient of Greenwich Excellence awards in banking.
Zions Bancorporation (NASDAQ:ZION) topped its 52-week high price of $59.19 on 05/22/18 and 52-Week Low Price of $45.20 on 10/22/18. The Stock currently has P/E (price to earnings ttm) of 12.73 and Weekly volatility of 2.15% and monthly volatility of 2.43% respectively.